Asian shares climbed after President Donald Trump delayed tariffs on Mexico and Canada for a month, and said he’d hold further talks with China.Stocks in Australia and Japan gained, while contracts for Hong Kong stocks also looked up.US stocks fell on Monday.Here’s a table showing how US stocks performed on Monday:

Source: EquitymasterAt present, the BSE Sensex is trading 467 points higher and NSE Nifty is trading 149 points higher.Infosys, Hindalco, and ONGC are among the top gainers today.Trent, HUL, and Nestle on other hand are among the top losers today.The BSE Midcap index is trading 1.1% higher and the BSE Smallcap index is trading 0.8% higher.Barring the FMCG sector, all other sectoral indices are trading on a positive note today with stocks in the IT sector and athe uto sector witnessing buying.The rupee is trading at Rs 87.02 against the US dollar.
 HFCL Q3 ResultsHFCL Ltd, a domestic telecom gear manufacturer, reported a 10.4% year-on-year (YoY) decline in net profit for Q3FY25, with earnings of Rs 737 m compared to Rs 822 m in the same period last year. Revenue from operations also saw a slight dip of 2%, coming in at Rs 10,120 m against Rs 10,323 m in the previous fiscal’s corresponding quarter.Despite the drop in profit and revenue, the company posted strong operational performance, with EBITDA surging 30% to Rs 1,518 m from Rs 1,168 m in Q3FY24. The EBITDA margin improved significantly to 15%, up from 11.3% in the year-ago quarter, reflecting better cost efficiencies.Mahendra Nahata, Managing Director of HFCL, highlighted the company’s resilience amid a dynamic and challenging market environment. He emphasized that recent BharatNet order wins reaffirm HFCL’s expertise in bolstering India’s digital infrastructure and strengthening its position as a trusted technology partner in the country’s broadband expansion.Tata Chemicals Q3 ResultsTata Chemicals Ltd reported a net loss of Rs 210 m for Q3FY25, compared to a net profit of Rs 1,940 m in the same quarter of the previous fiscal.The loss was primarily due to an exceptional charge of Rs 700 m, which covered estimated expenses related to employee termination benefits, decommissioning of plant and machinery, and other closure-related costs following the cessation of soda ash production at the Lostock plant in Northwich, UK.Revenue from operations declined 3.8% year-on-year to Rs 35.9 bn, down from Rs 37.3 bn in Q3FY24. At the operating level, EBITDA fell 19.9% to Rs 4.3 bn, compared to Rs 5.4 bn in the year-ago period, leading to a contraction in the EBITDA margin to 12.1% from 14.5% in the previous fiscal.During the quarter, the company commissioned a 70 KTPA pharma salt plant in the UK. Meanwhile, sales and production volumes of soda ash, bicarbonate, and salt were higher compared to the same period last year.
 Gland Pharma Revenue Dips 10%Gland Pharma Ltd reported a 6.7% year-on-year rise in net profit to Rs 2,047 million for Q3FY25, compared to Rs 1,919 million in the same quarter of the previous fiscal. However, revenue from operations declined by 10.4% year-on-year to Rs 13,840 million, down from Rs 15,452 million in Q3FY24.At the operating level, EBITDA increased by 1% to Rs 3,600 million, up from Rs 3,564 million in the year-ago period, with the EBITDA margin improving to 26% from 23.1%.During the quarter, the company launched 13 new molecules, including chlorpromazine, dexamethasone, phenylephrine, phytonadione, and diphenhydramine. Additionally, it filed four ANDAs and received approvals for eight.As of Q3FY25, Gland Pharma’s cumulative US ANDA filings stand at 366, with 312 approvals and 54 pending. The company’s global product registrations have reached 1,736. R&D expenses for the quarter amounted to Rs 437 million, representing 4.3% of revenue.
 Garden Reach Shipbuilders Declares DividendGarden Reach Shipbuilders Ltd. announced its December quarter results post-market hours on February 3, reporting robust year-on-year growth in revenue and profit, along with improved margins.The company’s revenue surged 37% to Rs 12,710 m, driven by steady execution of orders, while net profit rose 12% to Rs 980 m compared to the same period last year, reflecting operational efficiency and strong order inflows.At the operating level, EBITDA grew 55% to Rs 756.3 million, with EBITDA margins expanding by nearly 70 basis points to 5.95% from 5.27% in the previous year. The management attributed the margin expansion to better cost control and an improved product mix.In addition, the company declared a record interim dividend of Rs 8.95 per share, surpassing the Rs 7.92 per share announced in February last year, reinforcing its commitment to rewarding shareholders.The record date for the dividend payout has been set for 7 February 2025.Looking ahead, the management highlighted a strong order book, with ongoing projects progressing well in line with expectations. The company remains optimistic about securing additional orders in the coming months, further strengthening its position in the shipbuilding and defense sector.With continued government support for indigenous defense manufacturing and increasing demand for naval vessels, Garden Reach Shipbuilders is well-placed to capitalize on future opportunities.More By This Author:Sensex Today Ends 319 Points Lower; Nifty Below 23,400Sensex Today Trades Lower; Nifty Below 23,300Sensex Today Rallies 741 Points; Nifty Above 23,500